9 Reasons Perimenopause Drives Disordered Eating — and Why It Has Neurobiological Roots, Not Just Emotional Ones
The women who come to this site and quietly mention that they've started hiding food, or bingeing after years of normal eating, or obsessing over their changing body in ways that feel unfamiliar — they often preface it with 'I know this sounds silly.' It doesn't sound silly. It sounds like a nervous system that has had its hormonal scaffolding pulled away. The shame around this one runs deep, and it absolutely should not.
Learn more about Rose →Estrogen withdrawal disrupts serotonin signaling — the same pathway targeted by eating disorder treatments
Estrogen upregulates serotonin receptor density and slows serotonin reuptake, which is why its decline in perimenopause directly reduces serotonergic tone in the brain. Low serotonin is strongly implicated in both binge eating disorder and restrictive eating patterns, and it is not coincidental that SSRIs — drugs that boost serotonin — are among the few pharmacological treatments used for eating disorders. When estrogen drops, the neurochemical environment can begin to resemble the one seen in clinical eating disorder populations, independent of any psychological history.
Fluctuating estrogen destabilizes dopamine reward circuits, making highly palatable foods neurologically compelling
Estrogen modulates dopamine synthesis and receptor sensitivity in the mesolimbic reward system — the brain pathway responsible for craving, motivation, and the pleasure derived from food. During perimenopausal estrogen fluctuations, dopamine signaling becomes erratic, which can make high-fat, high-sugar foods feel urgently rewarding in a way that was not previously the case. This is not weak willpower; it is a measurable shift in the brain's incentive salience system, the same one implicated in addiction research.
Progesterone decline removes a natural appetite-regulating and anxiety-buffering compound
Progesterone and its neurosteroid metabolite allopregnanolone act on GABA-A receptors in the brain, producing calming, anti-anxiety effects that also help regulate the stress response around eating. As progesterone drops in perimenopause — often before estrogen does — this GABAergic buffer diminishes, leaving women more vulnerable to anxiety-driven eating behaviors including both restriction and bingeing. Allopregnanolone specifically has been shown in animal models to modulate food intake, and its loss is rarely discussed in clinical conversations about midlife appetite changes.
Cortisol dysregulation, driven by hormonal flux, creates a neurobiological setup for stress eating
The HPA axis — the body's stress response system — is regulated in part by estrogen and progesterone, and perimenopause disrupts that regulation, leading to elevated and less predictable cortisol output. High cortisol increases appetite, preferentially drives cravings for calorie-dense foods, and impairs the prefrontal cortex function needed to resist those urges. The combination of higher cortisol reactivity and lower hormonal buffering means that stress eating in perimenopause has a neurochemical foundation, not just a behavioral one.
Sleep disruption — itself hormonally driven — compounds every eating disorder risk factor simultaneously
Hot flashes, night sweats, and progesterone-related insomnia fragment sleep in ways that are well-documented in perimenopausal women, and even one night of poor sleep measurably increases ghrelin (the hunger hormone), decreases leptin (the satiety hormone), and reduces prefrontal inhibitory control. The result is a physiological state where hunger signals are amplified, fullness signals are muted, and the cognitive braking system that moderates impulsive eating is compromised — all at once. Chronic sleep deprivation in perimenopause can therefore sustain disordered eating patterns through a completely separate hormonal mechanism.
Rapid, unpredictable body composition changes can trigger body dysmorphic thinking even in women with no prior history
Perimenopausal estrogen decline causes a measurable redistribution of fat from the hips and thighs to the abdomen, alongside changes in muscle mass and skin texture, often within a relatively short timeframe. For women who have maintained a stable relationship with their bodies for decades, this sudden change can provoke cognitive distortions about size and shape that meet clinical criteria for body dysmorphia — not because of vanity, but because the brain struggles to update its body schema quickly enough. Research on body image in midlife women is sparse, but what exists consistently shows that body dissatisfaction peaks during perimenopause, not adolescence.
A history of eating disorders significantly raises the risk of relapse during perimenopause, and almost no one warns women about this
Women who recovered from anorexia, bulimia, or binge eating disorder in their 20s or 30s are at substantially elevated risk of relapse during perimenopause, likely because the same hormonal instability that drives initial onset in adolescence is recapitulated in the menopausal transition. Studies examining eating disorder trajectories across the lifespan show a secondary peak in midlife that is not adequately accounted for in clinical practice or treatment guidelines. Women in recovery deserve explicit, proactive conversations with their healthcare providers about this risk window — conversations that are currently the exception rather than the rule.
Insulin resistance — increasingly common in perimenopause — creates blood sugar volatility that mimics and amplifies binge urges
Estrogen plays a protective role in insulin sensitivity, and its perimenopausal decline often coincides with the early emergence of insulin resistance, even in previously metabolically healthy women. Unstable blood glucose produces physical hunger signals, cognitive impairment, and mood dysregulation that can be indistinguishable from emotional binge urges, and eating high-glycemic foods in response creates a reinforcing cycle. This metabolic dimension of disordered eating in midlife is rarely addressed in eating disorder treatment, despite being physiologically tractable.
Clinical neglect of midlife women in eating disorder research means most diagnostic tools and treatments were never designed for this population
The dominant research paradigm in eating disorders has focused overwhelmingly on adolescent and young adult women, meaning that validated screening tools, diagnostic criteria, and treatment protocols have not been tested for relevance or accuracy in perimenopausal populations. A woman in her late 40s presenting with new-onset binge eating, food restriction, or extreme weight preoccupation is statistically less likely to be screened for an eating disorder than a teenager with the same symptoms — a disparity with real clinical consequences. Until research funding and clinical attention shift to include midlife women, the neurobiological roots of perimenopausal disordered eating will continue to be misattributed, undertreated, or dismissed entirely.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.